Product Quantum (Rs. Cr) Long Term Rating Short Term Rating
Bank Loan Ratings 51.79 ACUITE BBB | Reaffirmed & Withdrawn -
Bank Loan Ratings 0.02 Not Applicable | Withdrawn -
Bank Loan Ratings 6.00 - ACUITE A3+ | Reaffirmed & Withdrawn
Total Outstanding 0.00 - -
Total Withdrawn 57.81 - -
 
Rating Rationale

­­Acuité has reaffirmed and withdrawn the long-term rating of ‘ACUITE BBB’ (read as ACUITE triple B) and the short-term rating of 'ACUITE A3+' (read as ACUITE A three plus) on the Rs 57.79 crore bank facilities of Ivis International Private Limited (IIPL). Acuité has also withdrawn the long-term rating on the Rs.0.02 crore bank Facilities of Ivis International Private Limited (IIPL). The same is withdrawn without assigning any rating as it is a proposed facility. The withdrawal is in accordance with Acuite's policy on withdrawal of ratings as applicable to the respective facility / instrument. The rating is being withdrawn on account of request received from the company, and NOC (No Objection Certificate) received from the banker.

Rationale for Rating Reaffirmation
The rating reaffirmation is driven by the stable operating performance of the group in FY2023 as compared to FY2022. The operating income of the group stood at Rs.137.05 Cr. in FY2023 as against Rs.132.25 Cr. in FY2022. The operating margin stood at 42.71 percent in FY2023 as against 43.17 percent in FY2022. Despite the marginal decline in operating margin, the margin remains healthy. The PAT margin of the group also remains healthy and stood at 20.29 percent in FY2023 and 20.21 percent in FY2022.
The financial risk profile of Provigil Group stands healthy marked by moderate tangible net worth, low gearing levels and comfortable debt protection metrics.
The rating reaffirmation also considers the long track record of the company and long-standing experience of the promotors, which is expected to help the company to augment its revenue further.


About Company

­­Incorporated in October 2014 in Telangana, Ivis International Private Limited is engaged in providing video monitoring services to banks & financial institutions for ATMs, retail outlets, warehouses and government institutions. Ivis is a part of the larger Provigil Group (defined later in the document) which is also engaged in similar line of business. Further, the company also sells the video monitoring equipment to its customers, depending upon the nature of the order. Mr. Prabhakara Rao Bollina, Mr. Rachapoodi Venkata Nagendra Murali Mohan, Mr. Ameeruddin Syed and Mr. Joseph Sudheer Reddy Thumma are the directors of the company.

 
About the Group

­­Ivis International Private Limited and Provigil Surveillance Limited are together referred to as Provigil Group. Since 2007, Provigil was initially engaged in the business of providing technology and back-end monitoring operations to US-based Provigil Inc. which was incorporated in 2006. However, Provigil Inc. has now been bought by a US-based private equity firm and looks after the US operations, whereas Provigil has been retained by the current management to look after the Indian operations. Currently, Ivis and Provigil are engaged providing video monitoring services to banks & financial institutions for ATMs, retail outlets, warehouses and government institutions. Further, both the companies also sell the video monitoring equipment to its customers, depending upon the nature of the order. Since Provigil as a brand has more experience in the market, most of the orders are currently routed through Provigil, although Ivis executes those orders.

 
Unsupported Rating

­Not Applicable

 
Analytical Approach

Extent of Consolidation
•Full Consolidation
Rationale for Consolidation or Parent / Group / Govt. Support

­­Acuité has consolidated the business and financial risk profiles of Ivis International Private Limited and Provigil Surveillance Limited to arrive at the rating. The consolidation is in the view of the similarities in the lines of business, operational & financial synergies and common management.

Key Rating Drivers

Strengths

­Experienced management and long track record of operation
­Provigil Group possesses an experience of over 14 years in the video monitoring services segment. The operations are managed by Mr. Prabhakara Rao Bollina, Mr. Rachapoodi Venkata Nagendra Murali Mohan, Mr. Ameeruddin Syed and Mr. Joseph Sudheer Reddy Thumma. Acuité believes that the long standing experience of the promoters has helped the company to build healthy relationship with reputed customers and service providers. 
The operating income stood at Rs.137.05 Cr. as on FY2023 as against Rs.132.25 Cr. in FY2022.  The operating margins stood at stood at 42.71% in FY2023 as against 43.17% in FY2022. The PAT margin of the group also remains healthy and stood at 20.29% in FY2023 and 20.21% in FY2022.

 

Healthy financial risk profile
The financial risk profile of the company continues to remain healthy marked by low gearing ratios, moderate net-worth and comfortable debt protection metrics. The gearing level stood at of 0.77 times as on March 31, 2023 as against 0.41 times as on March 31, 2022. TOL/TNW stood at 1.25 times as on March 31, 2023 and 0.81 times as on March 31, 2022. NCA/TD stood at 0.63 times and 1.19 times on March 31, 2023 and on March 31, 2022 respectively. 
Debt protection indicators are comfortable with interest coverage ratio (ICR) at 11.89 times as on March 31, 2023 as against 12.53 times on March 31, 2022. Debt service coverage ratio (DSCR) stood at 3.26 times on March 31, 2023 as against 3.69 times on March 31, 2022.


Weaknesses

­Working capital intensive nature of operations
The operations of Provigil Group are working capital intensive in nature with GCA of 275 days as on March 31, 2023. The working capital intensive nature of operations is primarily on account of higher receivable period despite agreed payment terms of 40-45 days with their customers (majorly banks). The reason for the same as certain banks holds back their dues in form of retention up to 2-4 months and release the same upon the installation of further sites. Moreover, in certain cases, the banks approve the invoices raised, only after the certification of the newly installed sites. Given all of the above, the Group’s receivable period stood at 103 days in FY2023 as against 86 days in FY2022. The inventory holding stood at 46 days in FY2023 as against 35 days in FY2022, whereas the inventory comprises of video surveillance parts.
The working capital requirements are majorly funded by way of internal accruals, and the average working capital utilization in the last 12 months ended December 2023 remained moderate at 53.19% for the group.

Rating Sensitivities

­Not Applicable

 
Liquidity Position
Adequate

­The Group generated healthy net cash accruals worth Rs. 46.17 Cr. and Rs. 44.37 Cr. in FY2023 and FY2022 respectively as against moderate debt repayment obligations Rs. 9.98 Cr. and Rs. 8.66 Cr. in those respective years. Furthermore, the current ratio stood healthy at 2.19 times as on March 31, 2023 as against 2.24 times as on March 31, 2022. The working capital requirements are majorly funded by way of internal accruals, whereas the average CC utilization in the last 12 months ended December 2023 stood moderately at 53.19% for the group. The cash and bank balance of the group is Rs.42.07 Cr. as on March 31 2023.

 
Outlook:

­Not Applicable

 
Other Factors affecting Rating

­None

 

Particulars Unit FY 23 (Actual) FY 22 (Actual)
Operating Income Rs. Cr. 137.05 132.25
PAT Rs. Cr. 27.81 26.73
PAT Margin (%) 20.29 20.21
Total Debt/Tangible Net Worth Times 0.77 0.41
PBDIT/Interest Times 11.89 12.53
Status of non-cooperation with previous CRA (if applicable)

­Not Applicable

 
Any Other Information

­None

 
Applicable Criteria
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm
• Consolidation Of Companies: https://www.acuite.in/view-rating-criteria-60.htm
• Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm
• Service Sector: https://www.acuite.in/view-rating-criteria-50.htm

Note on Complexity Levels of the Rated Instrument

­In order to inform the investors about complexity of instruments, Acuité has categorized such instruments in three levels: Simple, Complex and Highly Complex. Acuite’ s categorisation of the instruments across the three categories is based on factors like variability of the returns to the investors, uncertainty in cash flow patterns, number of counterparties and general understanding of the instrument by the market. It has to be understood that complexity is different from credit risk and even an instrument categorized as 'Simple' can carry high levels of risk. For more details, please refer Rating Criteria “Complexity Level Of Financial Instruments” on www.acuite.in.

 

Date Name of Instruments/Facilities Term Amount (Rs. Cr) Rating/Outlook
10 Apr 2023 Secured Overdraft Long Term 7.00 ACUITE BBB | Stable (Reaffirmed)
Term Loan Long Term 6.00 ACUITE BBB | Stable (Reaffirmed)
Term Loan Long Term 19.66 ACUITE BBB | Stable (Reaffirmed)
Term Loan Long Term 11.89 ACUITE BBB | Stable (Reaffirmed)
Term Loan Long Term 5.59 ACUITE BBB | Stable (Reaffirmed)
Term Loan Long Term 1.65 ACUITE BBB | Stable (Reaffirmed)
Proposed Long Term Bank Facility Long Term 0.02 ACUITE BBB | Stable (Reaffirmed)
Bank Guarantee (BLR) Short Term 6.00 ACUITE A3+ (Reaffirmed)
10 Jan 2022 Term Loan Long Term 13.23 ACUITE BBB | Stable (Assigned)
Term Loan Long Term 2.87 ACUITE BBB | Stable (Assigned)
Term Loan Long Term 9.86 ACUITE BBB | Stable (Assigned)
Term Loan Long Term 8.42 ACUITE BBB | Stable (Assigned)
Term Loan Long Term 3.43 ACUITE BBB | Stable (Assigned)
Term Loan Long Term 7.00 ACUITE BBB | Stable (Assigned)
Secured Overdraft Long Term 7.00 ACUITE BBB | Stable (Assigned)
Bank Guarantee (BLR) Short Term 6.00 ACUITE A3+ (Assigned)
­

Lender’s Name ISIN Facilities Date Of Issuance Coupon Rate Maturity Date Quantum
(Rs. Cr.)
Complexity Level Rating
HDFC Bank Ltd Not avl. / Not appl. Bank Guarantee (BLR) Not avl. / Not appl. Not avl. / Not appl. 07 Sep 2025 6.00 Simple ACUITE A3+ | Reaffirmed & Withdrawn
Not Applicable Not avl. / Not appl. Proposed Long Term Bank Facility Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 0.02 Simple Not Applicable|Withdrawn
HDFC Bank Ltd Not avl. / Not appl. Secured Overdraft Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 7.00 Simple ACUITE BBB | Reaffirmed & Withdrawn
HDFC Bank Ltd Not avl. / Not appl. Term Loan 07 Sep 2020 Not avl. / Not appl. 07 Sep 2025 6.00 Simple ACUITE BBB | Reaffirmed & Withdrawn
HDFC Bank Ltd Not avl. / Not appl. Term Loan 30 Sep 2022 Not avl. / Not appl. 07 Jan 2028 19.66 Simple ACUITE BBB | Reaffirmed & Withdrawn
HDFC Bank Ltd Not avl. / Not appl. Term Loan 28 Jun 2023 Not avl. / Not appl. 07 Aug 2029 11.89 Simple ACUITE BBB | Reaffirmed & Withdrawn
HDFC Bank Ltd Not avl. / Not appl. Term Loan 08 Nov 2019 Not avl. / Not appl. 07 Apr 2024 5.59 Simple ACUITE BBB | Reaffirmed & Withdrawn
HDFC Bank Ltd Not avl. / Not appl. Term Loan 22 Jun 2020 Not avl. / Not appl. 07 Jul 2024 1.65 Simple ACUITE BBB | Reaffirmed & Withdrawn
­
*Annexure 2 - List of Entities (applicable for Consolidation or Parent / Group / Govt. Support)

1. Ivis International Private Limited
2. Provigil Surveillance Limited

 

Contacts




About Acuité Ratings & Research

© Acuité Ratings & Research Limited. All Rights Reserved.www.acuite.in